Trulieve Cannabis (TCNNF) Change in Accured Expenses (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Change in Accured Expenses of -$3.9 million in Q1 2026, down 262.07% quarter-over-quarter from $2.4 million in Q4 2025, and down 1630.22% on a YoY basis from $254407.5 in Q1 2025.
Trulieve Cannabis (TCNNF) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 1630.22% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$14.9 million (down 351.19% YoY), while the FY2025 annual figure was -$11.3 million, down 256.24% from the prior year.
- Change in Accured Expenses was -$3.9 million for Q1 2026 at Trulieve Cannabis, down from $2.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $19.8 million in Q3 2023 to a low of -$36.0 million in Q4 2023.
- Historically, Change in Accured Expenses has averaged -$2.4 million across 5 years, with a median of -$225000.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Change in Accured Expenses soared 1889.41% in 2023, then slumped 1630.22% in 2026.
- A 5-year view of Change in Accured Expenses shows it stood at $3.2 million in 2022, then slumped by 1218.0% to -$36.0 million in 2023, then surged by 123.09% to $8.3 million in 2024, then plunged by 71.06% to $2.4 million in 2025, then slumped by 262.07% to -$3.9 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.9 million (Q1 2026), $2.4 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | -4.95 Mn |
| Sep 30, 2025 | -4.95 Mn |
| Jun 30, 2025 | -8.49 Mn |
| Jun 30, 2025 | -8.49 Mn |
| Mar 31, 2025 | -225,000.00 |
| Mar 31, 2025 | -225,000.00 |
| Dec 31, 2024 | 8.30 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | -35.96 Mn |
| Dec 31, 2023 | -35.96 Mn |